Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Cell. 2010 Jul 15;142(2):203–217. doi: 10.1016/j.cell.2010.06.001

Table 1.

Clinical phenotype associated withSRD5A3 mutations

CVH-385 MR3 08–0487/86 08–0904 07–0153 07–0419 AK0295
Ethnic background Baluchi Baluchi Polish Turkish Polish Turkish Turkish
Consanguinity + + + + + +
Muscle hypotonia/motor retardation +/− + + + + + +
Mental retardation + + + + + +/− +
Cerebellar atrophy/vermis malformations + NA + + + +
Spasticity +/− +/− +
Movement disorder/dystonia +/− + +/−
Visual loss +/− + + + + +/− +
Hypoplasia or coloboma/iris/retina/chorioid/optic
disc
+ + + + + +
Nystagmus + + + + + + +
Optic atrophy + + + + +
Other eye malformation
(microphthalmia /glaucoma/cataract)
microphthalmia + cataract glaucoma microphthalmia
cataract
Cardiac malformation/cardiac hypertrophy +
Ichtiosis/erythroderma + + + +
Dry skin/atopic dermatitis + + +/ − + +
Inverted nipples + +
Joint contractures +/−
Swallowing problems + + +
Failure to thrive + +
Microcitic anemia + + + + +
Elevated liver enzymes + NA + + + + +
Abnormal coagulation studies NA NA + + + + +
Decreased antithrombine 3/protein C and S levels NA NA + + + + +
Mutation cDNA c.402_404 delinsTGAGTAAGGC c.292_293del c.320 G>A het c.424 C>T
het c.524 C>A
c.29 C>A Genomic
rearrangement
Mutation at protein level p.Gln96delinsX p.Leu98ValfsX121 p.Trp107X p.Arg142X
p.Tyr163X
p.Ser10X Absent

NA: data not available